Transplantation, Kidney Clinical Trial
Official title:
An Open, Multicenter, Randomised, Parallel Group Pilot Study to Investigate Two Different Polyclonal Rabbit Immunoglobulin Preparations for Safety and Efficacy:A Comparison of ATG-Fresenius S to Thymoglobulin in Prophylaxis for Immunological High Risk Patients Following Renal Transplantation
An open, multicenter, randomised, parallel group pilot study to investigate two different polyclonal rabbit immunoglobulin preparations for safety and efficacy: A comparison of ATG-Fresenius S to Thymoglobulin in prophylaxis for immunological high risk patients following renal transplantation. This non-inferiority trial shall demonstrate that ATG-Fresenius S is as efficacious as Thymoglobulin but has a better tolerance and fewer side effects.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00189735 -
A Study to Evaluate FK778 in Kidney Transplant Patients
|
Phase 2 | |
Recruiting |
NCT01150487 -
Paired Marrow Aspirations to Assess Assays in Sensitized Renal Allograft Recipients
|
N/A | |
Completed |
NCT01656343 -
Belatacept and Risk of Post-transplant Lymphoproliferative Disorder in US Renal Transplant Recipients
|
||
Completed |
NCT02625428 -
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?
|
Phase 4 | |
Not yet recruiting |
NCT00617474 -
The Effect of Erythropoietin Usage in Renal Function After Kidney Transplantation, in Early Phase, in Contrast to Placebo Group
|
Phase 1 | |
Terminated |
NCT00365833 -
CEC/EPC and Cardiovascular Risk in Renal Transplant Recipients
|
N/A | |
Withdrawn |
NCT01496729 -
Transversus Abdominis Plane (TAP) Block After Kidney Transplantation
|
N/A | |
Completed |
NCT00614081 -
GFR Measurement With Contrast-enhanced Dynamic MRI
|
N/A | |
Completed |
NCT03977051 -
Exploring Immunosuppressant Medication Adherence in Kidney Transplant Patients
|
||
Terminated |
NCT00568477 -
Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
|
Phase 2 | |
Completed |
NCT04874740 -
Seroprevalence of the Anti-SARS-CoV-2 Antibodies (Causing COVID-19) in Kidney Transplant Recipients in Severely Affected Region
|
||
Available |
NCT01236287 -
Special Access for the Use of Voclosporin for Kidney Transplantation
|